Oncology
Amar Kelkar, M.D.
Physician in Medical Oncology, Dana-Farber Cancer Institute; Associate Physician, Brigham and Women's Hospital; Instructor in Medicine, Harvard Medical School
Dr. Amar Kelkar is a hematologic oncology physician at Dana-Farber Cancer Institute specializing in stem cell transplantation and hematologic malignancies. His clinical practice focuses on blood cancers and bone marrow transplant patients, with particular expertise in medical oncology. Beyond direct patient care, Dr. Kelkar pursues research interests in health economics, cost-effectiveness analysis, medical ethics, and health policy as a member of the Abel Laboratory. His work emphasizes improvi
11+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
Education & Training
- Harvard School of Public Health — Master of Public Health, Clinical Effectiveness, 2021-2023
- Dana-Farber Cancer Institute — Stem Cell Transplantation Fellowship, 2021-2022
- University of Florida College of Medicine — Fellowship, Hematology and Medical Oncology, 2018-2021
- University of Illinois College of Medicine at Peoria — Chief Residency, Internal Medicine, 2017-2018
- University of Illinois College of Medicine at Peoria — Residency, Internal Medicine, 2015-2018
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
11+ years in practice